Ben Mulhearn

@bath.ac.uk

Academic Clinical Fellow, Department of Life Sciences
University of Bath



                    

https://researchid.co/benmoleskin

EDUCATION

2005 - BSc Basic Clinical Sciences - St George's Hospital Medical School (University of London)
2008 - MBBS Medicine - St George's Hospital Medical School (University of London)
2011 - MSc Immunology with Immunogenetics - University of Manchester
2014 - MRCP (London)
2018 - PhD Immunology (medicine) - University of Manchester

RESEARCH INTERESTS

rheumatic diseases, immunology, precision medicine, cytometry, epidemiology, vasculitis, giant cell arteritis, VEXAS syndrome, rheumatoid arthritis, rheumatology

175

Scholar Citations

6

Scholar h-index

5

Scholar i10-index

RECENT SCHOLAR PUBLICATIONS

  • Relapse after cessation of weekly tocilizumab for giant cell arteritis: a multicentre service evaluation in England
    V Quick, M Abusalameh, S Ahmed, H Alkoky, M Bukhari, S Carter, ...
    Rheumatology, kead604 2023

  • Incidence of giant cell arteritis is associated with COVID-19 prevalence: A population-level retrospective study
    B Mulhearn, J Ellis, S Skeoch, J Pauling, S Tansley
    Heliyon 9 (7) 2023

  • POS0726 RITUXIMAB VERSUS CYCLOPHOSPHAMIDE FOR ANCA-ASSOCIATED VASCULITIS: A COST ANALYSIS
    E Amor, B Mulhearn, W Tillett, C Cavill, S Tansley
    Annals of the Rheumatic Diseases 82 (Suppl 1), 651-651 2023

  • Automated clustering reveals CD4+ T cell subset imbalances in rheumatoid arthritis
    B Mulhearn, L Marshall, M Sutcliffe, SK Hannes, C Fonseka, T Hussell, ...
    Frontiers in Immunology 14, 1094872 2023

  • Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported
    B Mulhearn
    Annals of the rheumatic diseases 82 (5), e115 2023

  • Monocular Vision Loss in a Patient With Earache and Night Sweats
    S Schimansky, G Cross, B Mulhearn
    JAMA ophthalmology 141 (4), 396-397 2023

  • P208 PET-CT scanning of GCA patients: the additive role of opportunistic screening for cardiovascular disease in a high-risk population
    B Mulhearn, J Ellis, R Foley, S Gunawardana, R Wickramarachchi, ...
    Rheumatology 62 (Supplement_2), kead104. 249 2023

  • P110 Challenges of meeting NICE guidance for rheumatoid arthritis in the modern era: a service audit
    H Cooney, J Ellis, B Mulhearn, A Allard
    Rheumatology 62 (Supplement_2), kead104. 151 2023

  • E070 How well is the mental health of rheumatoid arthritis patients assessed in the routine rheumatology clinic?
    H Cooney, J Ellis, B Mulhearn, A Allard
    Rheumatology 62 (Supplement_2), kead104. 319 2023

  • A Commercial Anti-TIF1g ELISA Is Superior to Line and Dot Blot and Should Be Considered as Part of Routine Myositis-Specific Antibody Testing
    B Mulhearn, D Li, F McMorrow, H Lu, NJ McHugh, SL Tansley
    Autoimmune Myositis: From Immunological to Rheumatological Aspects 2022

  • CD4+ T cell subset imbalance in rheumatoid arthritis: a case-control study
    B Mulhearn, L Marshall, M Sutcliffe, SK Hannes, C Fonseka, T Hussell, ...
    medRxiv, 2022.10. 20.22281307 2022

  • CD4+T cell subset imbalances in rheumatoid arthritis
    B Mulhearn, L Marshall, M Sutcliffe, S Hannes, C Fonseka, T Hussell, ...
    2022

  • The use of ELISA is comparable to immunoprecipitation in the detection of selected myositis-specific autoantibodies in a European population
    A Loganathan, F McMorrow, H Lu, D Li, B Mulhearn, NJ McHugh, ...
    Frontiers in Immunology 13, 975939 2022

  • Identification of Immune Cell Types in the Peripheral Blood of Rheumatoid Arthritis Patients Associated with Susceptibility and Response to Treatment
    M Christofi, B Mulhearn, L Marshall, M Sutcliffe, D Plant, K Hyrich, ...
    ARTHRITIS & RHEUMATOLOGY 74, 3447-3448 2022

  • GIANT CELL ARTERITIS PATIENT PATHWAY: A MULTI-DISCIPLINARY APPROACH TO SERVICE IMPROVEMENT IN THE TIME OF COVID-19
    B Mulhearn, J Ellis, S Smith, SL Tansley, S Skeoch
    RHEUMATOLOGY 61, I32-I32 2022

  • BASELINE MONOCYTE COUNT MAY HELP MAKE A DIAGNOSIS OF GIANT CELL ARTERITIS: RESULTS OF ROUTINELY COLLECTED AUDIT DATA FROM TWO CENTRES
    B Mulhearn, J Ellis, T Somoskeoy, A Bourn, S Knights, S Skeoch, ...
    RHEUMATOLOGY 61, I158-+ 2022

  • P190 Unsupervised automated clustering of mass cytometry data identifies unique CD4+ T cell subsets in rheumatoid arthritis
    B Mulhearn, L Marshall, M Sutcliffe, A Barton, S Raychaudhuri, S Viatte
    Rheumatology 61 (Supplement_1), keac133. 189 2022

  • P014 Giant Cell Arteritis Patient Pathway: A Multi-Disciplinary Approach to Service Improvement in the time of COVID-19
    B Mulhearn, J Ellis, S Smith, SL Tansley, S Skeoch
    Rheumatology 61 (Supplement_1), keac133. 013 2022

  • P016 Steroid prescribing and risk of adrenal insufficiency: an audit of giant cell arteritis cases
    J Ellis, L Ibbotson, B Mulhearn, S Skeoch
    Rheumatology 61 (Supplement_1), keac133. 015 2022

  • P290 Baseline monocyte count may help make a diagnosis of giant cell arteritis: results of routinely collected audit data from two centres
    B Mulhearn, J Ellis, T Somoskeoy, A Bourn, S Knights, S Skeoch, ...
    Rheumatology 61 (Supplement_1), keac133. 289 2022

MOST CITED SCHOLAR PUBLICATIONS

  • Indications for IVIG in rheumatic diseases
    B Mulhearn, IN Bruce
    Rheumatology 54 (3), 383-391 2015
    Citations: 99

  • Autoantibodies in connective tissue disease
    B Mulhearn, SL Tansley, NJ McHugh
    Best Practice & Research Clinical Rheumatology 34 (1), 101462 2020
    Citations: 22

  • Using the immunophenotype to predict response to biologic drugs in rheumatoid arthritis
    B Mulhearn, A Barton, S Viatte
    Journal of Personalized Medicine 9 (4), 46 2019
    Citations: 20

  • What rheumatologists need to know about innate lymphocytes
    MA Exley, GC Tsokos, KHG Mills, D Elewaut, B Mulhearn
    Nature Reviews Rheumatology 12 (11), 658-668 2016
    Citations: 11

  • A commercial anti-TIF1γ ELISA is superior to line and dot blot and should be considered as part of routine myositis-specific antibody testing
    B Mulhearn, D Li, F McMorrow, H Lu, NJ McHugh, SL Tansley
    Frontiers in Immunology 13, 804037 2022
    Citations: 10

  • Clinicoserological features of antisynthetase syndrome (ASyS)-associated interstitial lung disease presenting to respiratory services: comparison with idiopathic pulmonary
    SL Barratt, HH Adamali, C Cotton, B Mulhearn, H Iftikhar, JD Pauling, ...
    BMJ Open Respiratory Research 8 (1), e000829 2021
    Citations: 6

  • The use of ELISA is comparable to immunoprecipitation in the detection of selected myositis-specific autoantibodies in a European population
    A Loganathan, F McMorrow, H Lu, D Li, B Mulhearn, NJ McHugh, ...
    Frontiers in Immunology 13, 975939 2022
    Citations: 3

  • Rituximab fails to treat giant cell arteritis in a patient with ACPA-positive rheumatoid arthritis
    B Mulhearn, E Cooper, S Knights
    Rheumatology Advances in Practice 5 (1), rkab020 2021
    Citations: 2

  • Automated clustering reveals CD4+ T cell subset imbalances in rheumatoid arthritis
    B Mulhearn, L Marshall, M Sutcliffe, SK Hannes, C Fonseka, T Hussell, ...
    Frontiers in Immunology 14, 1094872 2023
    Citations: 1

  • OP0281 EXCESS GIANT CELL ARTERITIS CASES ARE ASSOCIATED WITH PEAKS IN COVID-19 PREVALENCE
    B Mulhearn, J Ellis, S Skeoch, J Pauling, S Tansley
    Annals of the Rheumatic Diseases 80 (Suppl 1), 170-170 2021
    Citations: 1